OncoGenex Pharma (OGXI) Tops Q3 EPS by 14c
Tweet
Share
E-mailGet Alerts OGXI Hot Sheet
Join SI Premium – FREE
OncoGenex Pharma (NASDAQ: OGXI) reported Q3 EPS of ($0.12), $0.14 better than the analyst estimate of ($0.26).
For earnings history and earnings-related data on OncoGenex Pharma (OGXI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Upgrades Aviva Plc (AV/:LN) (AIVAF) to Overweight
- Acrivon Therapeutics, Inc. (ACRV) Tops Q2 EPS by 21c
- ArriVent BioPharma, Inc. (AVBP) Misses Q2 EPS by 13c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
